Results 81 to 90 of about 7,383 (189)

Immune predictors of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer. [PDF]

open access: yesJ Immunother Cancer
Grau Bejar JF   +17 more
europepmc   +1 more source

Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study. [PDF]

open access: yesBlood Adv, 2021
Camus V   +31 more
europepmc   +1 more source

TEC-ADHERE: Real-World Persistence and Adherence on Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis in the French OroSEP Patient-Support Program. [PDF]

open access: yesNeurol Ther
Labauge P   +11 more
europepmc   +1 more source

IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer. [PDF]

open access: yesESMO Open, 2022
Molinier O   +20 more
europepmc   +1 more source

Successive Osteosarcoma Relapses after the First Line O2006/Sarcome-09 Trial: What Can We Learn for Further Phase-II Trials? [PDF]

open access: yesCancers (Basel), 2021
Thebault E   +19 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy